$VRDN Cashflow Statement | Understand Stock

$VRDN

$23.34 +$0.97 (4.34%) Close

$VRDN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash portion of acquired IPR&D
Share-based compensation expense
Amortization of financing issuance costs
Non-cash interest expense and amortization of debt issuance costs
Accretion and amortization of available-for-sale securities
Realized gain on investments
Net loss on extinguishment of debt
Fees paid directly to creditor related to extinguishment of debt
Loss on sale of equipment
Non-cash lease expenses
Non-cash interest expense
Depreciation and amortization
Issuance costs allocated to derivative liability
Change in fair value of derivative liability
Issuance of common stock under license agreement
Other non cash items
Changes in operating assets and liabilities:
Prepaid expenses, other current assets and other assets
Accounts payable
Accrued liabilities and other liabilities
Unbilled revenue
Deferred revenue

Net cash used in operating activities
Cash flows from investing activities:
Purchases of marketable securities
Proceeds from sale of short-term investments
Cash acquired in acquisition of Private Viridian
Proceeds from maturities of short-term investments
Maturities of marketable securities
Proceeds from sale of property and equipment
Purchases of property and equipment
Other
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from issuance of common stock in offerings
Proceeds from the issuance of common stock
Warrant
Total proceeds from the issuance of common stock

Proceeds from the issuance of Series B convertible preferred stock, pursuant to the 2023 Private Placement
Payment of issuance costs
Common Stock
Convertible Preferred Stock
Proceeds from the issuance of Series B convertible preferred stock in offerings
Series B Preferred Stock, as converted to shares of common stock
Series A Preferred Stock, as converted to shares of common stock
Total proceeds from the issuance of Series B convertible preferred stock in offerings

Proceeds from the exercise of warrants
Proceeds from issuance of long-term debt, net
Payment of debt extinguishment costs
Payment of debt issuance costs
Proceeds from sale of future revenue
Payment of issuance costs associated with sale of future revenue
Proceeds from issuance of common stock upon exercise of stock options
Proceeds from the issuance of common stock for cash under employee stock purchase plan
Payments of principal of notes payable
Proceeds from the issuance of notes payable
Fractional share payment – reverse split
Net cash provided by financing activities

Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information
Interest paid
Supplemental disclosure of non-cash investing and financing activities
Purchase of property and equipment in accounts payable and accrued liabilities
Unpaid common and convertible preferred stock issuance costs included in accrued liabilities
Unpaid common and convertible preferred stock issuance costs included in accounts payable
Issuance of common stock upon the conversion of convertible preferred stock
Right-of-use asset obtained in exchange for new lease liability
Remeasurement of right-of-use asset and lease liability for lease modifications
Extinguishment of long-term debt
Issuance of long-term debt
Amortization of public offering costs

Comments